_id
6911bafeccc777a4e85d619b
Ticker
GEHC
Name
GE HealthCare Technologies Inc.
Exchange
NASDAQ
Address
500 West Monroe Street, Chicago, IL, United States, 60661
Country
USA
Sector
Healthcare
Industry
Health Information Services
Currency
USD
Website
https://www.gehealthcare.com
Description
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Last Close
82.58
Volume
3084012
Current Price
87.855
Change
0.8
Last Updated
2026-01-03T12:29:28.018Z
Image
data:image/webp;base64,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
Ipo Date
2023-01-04T00:00:00.000Z
Market Cap
37812469760
Next Dividend Date
2026-02-13T00:00:00.000Z
Dividend Frequency
Quarterly
Dividend Rate
0.035
Dividend Yield
0.15935348016618292
Sentiment
0.914578787878788
Sentiment Sources
33
Rating
4.3333
Target Price
90.3
Strong Buy
12
Buy
4
Hold
5
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
5143000000
Cost Of Revenue
3153000000
Gross Profit
1990000000
Operating Expenses
1337000000
Operating Income
653000000
Interest Expense
111000000
Pretax Income
643000000
Net Income
446000000
Eps
0.975929978118162
Dividends Per Share
16000000
Shares Outstanding
455521592
Income Tax Expense
179000000
EBITDA
902000000
Operating Margin
12.696869531401905
Total Other Income Expense Net
-10000000
Cash
4005000000
Short Term Investments
-
Receivables
4681000000
Inventories
2304000000
Total Current Assets
11893000000
Property Plant Equipment
3010000000
Total Assets
36127000000
Payables
2987000000
Short Term Debt
2139000000
Long Term Debt
8277000000
Total Liabilities
25907000000
Equity
9993000000
Bs_currency_symbol
USD
Depreciation
148000000
Change In Working Capital
-87000000
Cash From Operations
593000000
Capital Expenditures
110000000
Cash From Investing
-148000000
Cash From Financing
-165000000
Net Change In Cash
264000000
Cf_currency_symbol
USD
PE
17.147
PB
4.017785950165115
ROE
4.463124186930852
ROA
1.234533728236499
FCF
483000000
Fcf Percent
0.09391405794283492
Piotroski FScore
4
Health Score
44
Deep Value Investing Score
4.5
Defensive Investing Score
8
Dividend Investing Score
4
Economic Moat Investing Score
6.8
Garp Investing Score
2.5
Growth Investing Score
3
Momentum Investing Score
6
Net Net Investing Score
2.5
Quality Investing Score
5.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
5143000000
Quarters > 0 > income Statement > cost Of Revenue
3153000000
Quarters > 0 > income Statement > gross Profit
1990000000
Quarters > 0 > income Statement > operating Expenses
1337000000
Quarters > 0 > income Statement > operating Income
653000000
Quarters > 0 > income Statement > interest Expense
111000000
Quarters > 0 > income Statement > pretax Income
643000000
Quarters > 0 > income Statement > net Income
446000000
Quarters > 0 > income Statement > eps
0.975929978118162
Quarters > 0 > income Statement > dividends Per Share
16000000
Quarters > 0 > income Statement > shares Outstanding
457000000
Quarters > 0 > income Statement > income Tax Expense
179000000
Quarters > 0 > income Statement > EBITDA
902000000
Quarters > 0 > income Statement > operating Margin
12.696869531401905
Quarters > 0 > income Statement > total Other Income Expense Net
-10000000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
4005000000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
4681000000
Quarters > 0 > balance Sheet > inventories
2304000000
Quarters > 0 > balance Sheet > total Current Assets
11893000000
Quarters > 0 > balance Sheet > property Plant Equipment
3010000000
Quarters > 0 > balance Sheet > total Assets
36127000000
Quarters > 0 > balance Sheet > payables
2987000000
Quarters > 0 > balance Sheet > short Term Debt
2139000000
Quarters > 0 > balance Sheet > long Term Debt
8277000000
Quarters > 0 > balance Sheet > total Liabilities
25907000000
Quarters > 0 > balance Sheet > equity
9993000000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
464000000
Quarters > 0 > cash Flow > depreciation
148000000
Quarters > 0 > cash Flow > change In Working Capital
-87000000
Quarters > 0 > cash Flow > cash From Operations
593000000
Quarters > 0 > cash Flow > capital Expenditures
110000000
Quarters > 0 > cash Flow > cash From Investing
-148000000
Quarters > 0 > cash Flow > cash From Financing
-165000000
Quarters > 0 > cash Flow > net Change In Cash
264000000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.975929978118162
Quarters > 0 > ratios > PB
4.017785950165115
Quarters > 0 > ratios > ROE
4.463124186930852
Quarters > 0 > ratios > ROA
1.234533728236499
Quarters > 0 > ratios > FCF
483000000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.09391405794283492
Quarters > 0 > health Score
44
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
5006000000
Quarters > 1 > income Statement > cost Of Revenue
3023000000
Quarters > 1 > income Statement > gross Profit
1985000000
Quarters > 1 > income Statement > operating Expenses
1329000000
Quarters > 1 > income Statement > operating Income
654000000
Quarters > 1 > income Statement > interest Expense
113000000
Quarters > 1 > income Statement > pretax Income
613000000
Quarters > 1 > income Statement > net Income
486000000
Quarters > 1 > income Statement > eps
1.0611353711790392
Quarters > 1 > income Statement > dividends Per Share
16000000
Quarters > 1 > income Statement > shares Outstanding
458000000
Quarters > 1 > income Statement > income Tax Expense
113000000
Quarters > 1 > income Statement > EBITDA
874000000
Quarters > 1 > income Statement > operating Margin
13.064322812624852
Quarters > 1 > income Statement > total Other Income Expense Net
-41000000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
3763000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
4475000000
Quarters > 1 > balance Sheet > inventories
2283000000
Quarters > 1 > balance Sheet > total Current Assets
10915000000
Quarters > 1 > balance Sheet > property Plant Equipment
2962000000
Quarters > 1 > balance Sheet > total Assets
35500000000
Quarters > 1 > balance Sheet > payables
2975000000
Quarters > 1 > balance Sheet > short Term Debt
2259000000
Quarters > 1 > balance Sheet > long Term Debt
8270000000
Quarters > 1 > balance Sheet > total Liabilities
25547000000
Quarters > 1 > balance Sheet > equity
9713000000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
500000000
Quarters > 1 > cash Flow > depreciation
148000000
Quarters > 1 > cash Flow > change In Working Capital
-251000000
Quarters > 1 > cash Flow > cash From Operations
94000000
Quarters > 1 > cash Flow > capital Expenditures
86000000
Quarters > 1 > cash Flow > cash From Investing
-223000000
Quarters > 1 > cash Flow > cash From Financing
1361000000
Quarters > 1 > cash Flow > net Change In Cash
1290000000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
1.0611353711790392
Quarters > 1 > ratios > PB
4.142653145269227
Quarters > 1 > ratios > ROE
5.003603418099455
Quarters > 1 > ratios > ROA
1.3690140845070424
Quarters > 1 > ratios > FCF
8000000
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.0015980823012385138
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
4777000000
Quarters > 2 > income Statement > cost Of Revenue
2765000000
Quarters > 2 > income Statement > gross Profit
2012000000
Quarters > 2 > income Statement > operating Expenses
1383000000
Quarters > 2 > income Statement > operating Income
629000000
Quarters > 2 > income Statement > interest Expense
111000000
Quarters > 2 > income Statement > pretax Income
692000000
Quarters > 2 > income Statement > net Income
564000000
Quarters > 2 > income Statement > eps
1.2287581699346406
Quarters > 2 > income Statement > dividends Per Share
16000000
Quarters > 2 > income Statement > shares Outstanding
459000000
Quarters > 2 > income Statement > income Tax Expense
104000000
Quarters > 2 > income Statement > EBITDA
939000000
Quarters > 2 > income Statement > operating Margin
13.167259786476867
Quarters > 2 > income Statement > total Other Income Expense Net
63000000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2473000000
Quarters > 2 > balance Sheet > short Term Investments
19000000
Quarters > 2 > balance Sheet > receivables
4350000000
Quarters > 2 > balance Sheet > inventories
2158000000
Quarters > 2 > balance Sheet > total Current Assets
9376000000
Quarters > 2 > balance Sheet > property Plant Equipment
2851000000
Quarters > 2 > balance Sheet > total Assets
33586000000
Quarters > 2 > balance Sheet > payables
3152000000
Quarters > 2 > balance Sheet > short Term Debt
2121000000
Quarters > 2 > balance Sheet > long Term Debt
6757000000
Quarters > 2 > balance Sheet > total Liabilities
24168000000
Quarters > 2 > balance Sheet > equity
9188000000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
588000000
Quarters > 2 > cash Flow > depreciation
136000000
Quarters > 2 > cash Flow > change In Working Capital
-143000000
Quarters > 2 > cash Flow > cash From Operations
250000000
Quarters > 2 > cash Flow > capital Expenditures
152000000
Quarters > 2 > cash Flow > cash From Investing
-407000000
Quarters > 2 > cash Flow > cash From Financing
-286000000
Quarters > 2 > cash Flow > net Change In Cash
-417000000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
1.2287581699346406
Quarters > 2 > ratios > PB
4.38892522855899
Quarters > 2 > ratios > ROE
6.138441445363518
Quarters > 2 > ratios > ROA
1.679271124873459
Quarters > 2 > ratios > FCF
98000000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.020514967552857442
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
5319000000
Quarters > 3 > income Statement > cost Of Revenue
3044000000
Quarters > 3 > income Statement > gross Profit
2275000000
Quarters > 3 > income Statement > operating Expenses
1474000000
Quarters > 3 > income Statement > operating Income
801000000
Quarters > 3 > income Statement > interest Expense
111000000
Quarters > 3 > income Statement > pretax Income
834000000
Quarters > 3 > income Statement > net Income
720000000
Quarters > 3 > income Statement > eps
1.5686274509803921
Quarters > 3 > income Statement > dividends Per Share
14000000
Quarters > 3 > income Statement > shares Outstanding
459000000
Quarters > 3 > income Statement > income Tax Expense
96000000
Quarters > 3 > income Statement > EBITDA
1085000000
Quarters > 3 > income Statement > operating Margin
15.059221658206429
Quarters > 3 > income Statement > total Other Income Expense Net
33000000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
2890000000
Quarters > 3 > balance Sheet > short Term Investments
15000000
Quarters > 3 > balance Sheet > receivables
4376000000
Quarters > 3 > balance Sheet > inventories
1939000000
Quarters > 3 > balance Sheet > total Current Assets
9516000000
Quarters > 3 > balance Sheet > property Plant Equipment
2550000000
Quarters > 3 > balance Sheet > total Assets
33089000000
Quarters > 3 > balance Sheet > payables
3022000000
Quarters > 3 > balance Sheet > short Term Debt
1617000000
Quarters > 3 > balance Sheet > long Term Debt
7449000000
Quarters > 3 > balance Sheet > total Liabilities
24436000000
Quarters > 3 > balance Sheet > equity
8447000000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
738000000
Quarters > 3 > cash Flow > depreciation
140000000
Quarters > 3 > cash Flow > change In Working Capital
215000000
Quarters > 3 > cash Flow > cash From Operations
913000000
Quarters > 3 > cash Flow > capital Expenditures
102000000
Quarters > 3 > cash Flow > cash From Investing
-240000000
Quarters > 3 > cash Flow > cash From Financing
-1277000000
Quarters > 3 > cash Flow > net Change In Cash
-679000000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
1.5686274509803921
Quarters > 3 > ratios > PB
4.773936900674796
Quarters > 3 > ratios > ROE
8.523736237717532
Quarters > 3 > ratios > ROA
2.1759497113844484
Quarters > 3 > ratios > FCF
811000000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.15247226922353826
Quarters > 3 > health Score
54
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
19672000000
Annuals > 0 > income Statement > cost Of Revenue
11467000000
Annuals > 0 > income Statement > gross Profit
8205000000
Annuals > 0 > income Statement > operating Expenses
5580000000
Annuals > 0 > income Statement > operating Income
2625000000
Annuals > 0 > income Statement > interest Expense
505000000
Annuals > 0 > income Statement > pretax Income
2581000000
Annuals > 0 > income Statement > net Income
1993000000
Annuals > 0 > income Statement > eps
4.342047930283225
Annuals > 0 > income Statement > dividends Per Share
55000000
Annuals > 0 > income Statement > shares Outstanding
459000000
Annuals > 0 > income Statement > income Tax Expense
531000000
Annuals > 0 > income Statement > EBITDA
3666000000
Annuals > 0 > income Statement > operating Margin
13.343838958926394
Annuals > 0 > income Statement > total Other Income Expense Net
-44000000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2890000000
Annuals > 0 > balance Sheet > short Term Investments
15000000
Annuals > 0 > balance Sheet > receivables
4376000000
Annuals > 0 > balance Sheet > inventories
1939000000
Annuals > 0 > balance Sheet > total Current Assets
9516000000
Annuals > 0 > balance Sheet > property Plant Equipment
2550000000
Annuals > 0 > balance Sheet > total Assets
33089000000
Annuals > 0 > balance Sheet > payables
3022000000
Annuals > 0 > balance Sheet > short Term Debt
1617000000
Annuals > 0 > balance Sheet > long Term Debt
7449000000
Annuals > 0 > balance Sheet > total Liabilities
24436000000
Annuals > 0 > balance Sheet > equity
8447000000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
2050000000
Annuals > 0 > cash Flow > depreciation
580000000
Annuals > 0 > cash Flow > change In Working Capital
-59000000
Annuals > 0 > cash Flow > cash From Operations
1951000000
Annuals > 0 > cash Flow > capital Expenditures
401000000
Annuals > 0 > cash Flow > cash From Investing
-914000000
Annuals > 0 > cash Flow > cash From Financing
-573000000
Annuals > 0 > cash Flow > net Change In Cash
387000000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
4.342047930283225
Annuals > 0 > ratios > PB
4.500340949449509
Annuals > 0 > ratios > ROE
23.594175446904224
Annuals > 0 > ratios > ROA
6.023149687207229
Annuals > 0 > ratios > FCF
1550000000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.07879219194794632
Annuals > 0 > health Score
58
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
19552000000
Annuals > 1 > income Statement > cost Of Revenue
11630000000
Annuals > 1 > income Statement > gross Profit
7922000000
Annuals > 1 > income Statement > operating Expenses
5487000000
Annuals > 1 > income Statement > operating Income
2435000000
Annuals > 1 > income Statement > interest Expense
542000000
Annuals > 1 > income Statement > pretax Income
2361000000
Annuals > 1 > income Statement > net Income
3104000000
Annuals > 1 > income Statement > eps
6.777292576419214
Annuals > 1 > income Statement > dividends Per Share
41000000
Annuals > 1 > income Statement > shares Outstanding
458000000
Annuals > 1 > income Statement > income Tax Expense
-743000000
Annuals > 1 > income Statement > EBITDA
2435000000
Annuals > 1 > income Statement > operating Margin
12.453968903436989
Annuals > 1 > income Statement > total Other Income Expense Net
-74000000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2504000000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
4315000000
Annuals > 1 > balance Sheet > inventories
1960000000
Annuals > 1 > balance Sheet > total Current Assets
9010000000
Annuals > 1 > balance Sheet > property Plant Equipment
2500000000
Annuals > 1 > balance Sheet > total Assets
32454000000
Annuals > 1 > balance Sheet > payables
2947000000
Annuals > 1 > balance Sheet > short Term Debt
1116000000
Annuals > 1 > balance Sheet > long Term Debt
8436000000
Annuals > 1 > balance Sheet > total Liabilities
25144000000
Annuals > 1 > balance Sheet > equity
7133000000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
1618000000
Annuals > 1 > cash Flow > depreciation
610000000
Annuals > 1 > cash Flow > change In Working Capital
22000000
Annuals > 1 > cash Flow > cash From Operations
2101000000
Annuals > 1 > cash Flow > capital Expenditures
387000000
Annuals > 1 > cash Flow > cash From Investing
-558000000
Annuals > 1 > cash Flow > cash From Financing
-478000000
Annuals > 1 > cash Flow > net Change In Cash
1055000000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
6.777292576419214
Annuals > 1 > ratios > PB
5.317756904528249
Annuals > 1 > ratios > ROE
43.51605215196972
Annuals > 1 > ratios > ROA
9.564306402908732
Annuals > 1 > ratios > FCF
1714000000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.08766366612111293
Annuals > 1 > health Score
59
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
18341000000
Annuals > 2 > income Statement > cost Of Revenue
11162000000
Annuals > 2 > income Statement > gross Profit
7179000000
Annuals > 2 > income Statement > operating Expenses
4657000000
Annuals > 2 > income Statement > operating Income
2522000000
Annuals > 2 > income Statement > interest Expense
86000000
Annuals > 2 > income Statement > pretax Income
2512000000
Annuals > 2 > income Statement > net Income
1916000000
Annuals > 2 > income Statement > eps
4.220951021284985
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
453926139
Annuals > 2 > income Statement > income Tax Expense
563000000
Annuals > 2 > income Statement > EBITDA
3165000000
Annuals > 2 > income Statement > operating Margin
13.750613379859331
Annuals > 2 > income Statement > total Other Income Expense Net
-10000000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1445000000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
3993000000
Annuals > 2 > balance Sheet > inventories
2155000000
Annuals > 2 > balance Sheet > total Current Assets
7819000000
Annuals > 2 > balance Sheet > property Plant Equipment
2314000000
Annuals > 2 > balance Sheet > total Assets
27539000000
Annuals > 2 > balance Sheet > payables
3090000000
Annuals > 2 > balance Sheet > short Term Debt
119000000
Annuals > 2 > balance Sheet > long Term Debt
8234000000
Annuals > 2 > balance Sheet > total Liabilities
17947000000
Annuals > 2 > balance Sheet > equity
9357000000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
1949000000
Annuals > 2 > cash Flow > depreciation
633000000
Annuals > 2 > cash Flow > change In Working Capital
-293000000
Annuals > 2 > cash Flow > cash From Operations
2113000000
Annuals > 2 > cash Flow > capital Expenditures
310000000
Annuals > 2 > cash Flow > cash From Investing
-398000000
Annuals > 2 > cash Flow > cash From Financing
-822000000
Annuals > 2 > cash Flow > net Change In Cash
890000000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
4.220951021284985
Annuals > 2 > ratios > PB
4.017758131022764
Annuals > 2 > ratios > ROE
20.47664849845036
Annuals > 2 > ratios > ROA
6.957405860779259
Annuals > 2 > ratios > FCF
1803000000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.09830434545553678
Annuals > 2 > health Score
66
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
17585000000
Annuals > 3 > income Statement > cost Of Revenue
10411000000
Annuals > 3 > income Statement > gross Profit
7174000000
Annuals > 3 > income Statement > operating Expenses
4379000000
Annuals > 3 > income Statement > operating Income
2795000000
Annuals > 3 > income Statement > interest Expense
40000000
Annuals > 3 > income Statement > pretax Income
2875000000
Annuals > 3 > income Statement > net Income
2247000000
Annuals > 3 > income Statement > eps
4.941611093298048
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
454710004
Annuals > 3 > income Statement > income Tax Expense
600000000
Annuals > 3 > income Statement > EBITDA
3540000000
Annuals > 3 > income Statement > operating Margin
15.89422803525732
Annuals > 3 > income Statement > total Other Income Expense Net
80000000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
556000000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
3791000000
Annuals > 3 > balance Sheet > inventories
1946000000
Annuals > 3 > balance Sheet > total Current Assets
6543000000
Annuals > 3 > balance Sheet > property Plant Equipment
2235000000
Annuals > 3 > balance Sheet > total Assets
26308000000
Annuals > 3 > balance Sheet > payables
2729000000
Annuals > 3 > balance Sheet > short Term Debt
110000000
Annuals > 3 > balance Sheet > long Term Debt
31000000
Annuals > 3 > balance Sheet > total Liabilities
9412000000
Annuals > 3 > balance Sheet > equity
16655000000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
2275000000
Annuals > 3 > cash Flow > depreciation
625000000
Annuals > 3 > cash Flow > change In Working Capital
-1370000000
Annuals > 3 > cash Flow > cash From Operations
1607000000
Annuals > 3 > cash Flow > capital Expenditures
248000000
Annuals > 3 > cash Flow > cash From Investing
-1761000000
Annuals > 3 > cash Flow > cash From Financing
-263000000
Annuals > 3 > cash Flow > net Change In Cash
-451000000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
4.941611093298048
Annuals > 3 > ratios > PB
2.261127741295707
Annuals > 3 > ratios > ROE
13.491444010807566
Annuals > 3 > ratios > ROA
8.541128173939486
Annuals > 3 > ratios > FCF
1359000000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.07728177423940859
Annuals > 3 > health Score
71
Valuation > metrics > PE
17.147
Valuation > metrics > PB
4.017785950165115
Valuation > final Score
69.82214049834884
Valuation > verdict
17.0% Overvalued
Profitability > metrics > ROE
4.463124186930852
Profitability > metrics > ROA
3.7501051038425963
Profitability > metrics > Net Margin
0.08671981333851837
Profitability > final Score
33
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.5925147603322327
Risk > metrics > Interest Coverage
5.882882882882883
Risk > final Score
42
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.3201326570425285
Liquidity > metrics > Quick Ratio
1.8706593835349201
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
58.573468547307726
Prev Valuations > 1
56.1107477144101
Prev Valuations > 2
52.260630993252036
Prev Profitabilities > 0
38
Prev Profitabilities > 1
48
Prev Profitabilities > 2
60
Prev Risks > 0
41
Prev Risks > 1
41
Prev Risks > 2
47
Prev Liquidities > 0
100
Prev Liquidities > 1
94
Prev Liquidities > 2
100
Updated At
2026-01-20T21:53:36.180Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-29
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
1.07
Earnings History > 0 > eps Estimate
1.04
Earnings History > 0 > eps Difference
0.03
Earnings History > 0 > surprise Percent
2.8846
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
1.06
Earnings History > 1 > eps Estimate
0.92
Earnings History > 1 > eps Difference
0.14
Earnings History > 1 > surprise Percent
15.2174
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-30
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
1.01
Earnings History > 2 > eps Estimate
0.91
Earnings History > 2 > eps Difference
0.1
Earnings History > 2 > surprise Percent
10.989
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-13
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
1.57
Earnings History > 3 > eps Estimate
1.26
Earnings History > 3 > eps Difference
0.31
Earnings History > 3 > surprise Percent
24.6032
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-10-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
1.14
Earnings History > 4 > eps Estimate
1.05
Earnings History > 4 > eps Difference
0.09
Earnings History > 4 > surprise Percent
8.5714
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-07-31
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
1
Earnings History > 5 > eps Estimate
0.98
Earnings History > 5 > eps Difference
0.02
Earnings History > 5 > surprise Percent
2.0408
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-04-30
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.9
Earnings History > 6 > eps Estimate
0.91
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-1.0989
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-06
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
1.18
Earnings History > 7 > eps Estimate
1.07
Earnings History > 7 > eps Difference
0.11
Earnings History > 7 > surprise Percent
10.2804
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-10-31
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.99
Earnings History > 8 > eps Estimate
0.9
Earnings History > 8 > eps Difference
0.09
Earnings History > 8 > surprise Percent
10
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-07-25
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.92
Earnings History > 9 > eps Estimate
0.87
Earnings History > 9 > eps Difference
0.05
Earnings History > 9 > surprise Percent
5.7471
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-04-25
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.85
Earnings History > 10 > eps Estimate
0.79
Earnings History > 10 > eps Difference
0.06
Earnings History > 10 > surprise Percent
7.5949
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-01-30
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
1.21
Earnings History > 11 > eps Estimate
1.06
Earnings History > 11 > eps Difference
0.15
Earnings History > 11 > surprise Percent
14.1509
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-12-08
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
1.11
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
1.11
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-09-13
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
1.9
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
1.9
Earnings History > 13 > surprise Percent
-
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
0.035Next Payout:
Feb 13, 2026Yield:
0.1594 %GE HealthCare Technologies Is A Hold Before Earnings (Technical Analysis) (NASDAQ:GEHC) Seeking Alpha
Read more →Massachusetts Financial Services Co. MA Cuts Holdings in GE HealthCare Technologies Inc. $GEHC MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$90.3
Analyst Picks
Strong Buy
12
Buy
4
Hold
5
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Medium
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of GE HealthCare Technologies Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
1.07
EPS Estimate
1.04
EPS Difference
0.03
Surprise Percent
2.8846%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.